|
Ranbaxy Laboratories Limited has signed a collaborative research agreement in the area of New Drug Discovery research with Avestha Gengraine Technologies Pvt Ltd to carry out project activity relating to construction of recombinant cell lines required for screening Ranbaxy's drug candidates, informed a press release.
Avesthagen is India's leading fully integrated biotechnology and bioinformatics company, focusing on the convergence between food, pharma and clinical genomics leading to preventive personalized medicine. Avesthagen provides innovative solutions for global challenges in health problems in the areas of degenerative conditions, metabolic disorders and infectious diseases, said the release. Ranbaxy, India's largest pharmaceutical company, manufactures and markets branded generic pharmaceuticals and Active Pharmaceutical Ingredients. The company sells its products in over 100 countries and has an expanding international portfolio of affiliates, joint ventures and alliances.
|